v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 29, 2026
Dec. 28, 2025
Stock-Based Compensation [Abstract]    
Schedule of Stock Option Activity

The information below summarizes the stock option activity under the Plans.

 

   Number of
Shares
   Weighted
Average
Exercise
Price per
Share
   Weighted
Average
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding—December 28, 2025   4,930,300   $4.62    5.58   $1,903 
Options exercised                   
Outstanding—March 29, 2026   4,930,300    4.62    5.74    1,376 
Vested and expected to vest — March 29, 2026   4,930,300    4.62    5.74    1,376 
Vested and exercisable — March 29, 2026   1,781,378    5.39    5.69    472 

The information below summarizes the stock option activity under the Plans.

 

   Number of
Shares
   Weighted
Average
Exercise
Price per
Share
   Weighted
Average
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding – December 31, 2023   11,716,646   $3.48    8.53   $2,756 
Options granted   6,121,251    0.93           
Options exercised   (398,883)   0.77         39 
Options cancelled   (7,441,781)   0.17           
Outstanding – December 29, 2024   9,997,233    2.77    5.29    6,356 
Options granted   
               
Options exercised   (712,467)   0.72         83 
Options cancelled   (4,354,466)   2.69           
Outstanding – December 28, 2025   4,930,300    4.62    5.58    1,903 
Vested and expected to vest— December 28, 2025   4,930,300    4.62    5.58    1,903 
Vested and exercisable— December 28, 2025   1,909,809    5.94    5.87    635 
Schedule of RSU Activity

The information below summarizes the RSU activity.

 

   Number of
RSUs
   Weighted
Average
Grant Date
Fair Value
 
Unvested at December 28, 2025   14,234,360   $1.73 
Vested and released   (863,030)   1.73 
Cancelled or forfeited   (2,070)   1.74 
Unvested at March 29, 2026   13,369,260    1.73 

The information below summarizes the RSU activity.

 

    Number of
RSUs
    Weighted
Average
Grant Date
Fair Value
 
Unvested at December 31, 2023     58,097     $ 2.07  
Granted     2,593,097       1.78  
Vested and released     (669,059 )     1.73  
Cancelled or forfeited            
Unvested at December 29, 2024     1,982,135       1.79  
Granted     22,235,871       1.73  
Vested and released     (4,632,212 )     1.75  
Cancelled or forfeited     (5,351,434 )     1.74  
Unvested at December 28, 2025     14,234,360       1.73  
Schedule of Statements of Operations and Comprehensive Loss

The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands):

 

   Thirteen Weeks Ended 
   March 29,   March 30, 
   2026   2025 
Cost of revenues  $485   $155 
Sales and marketing   466    184 
General and administrative   654    130 
Total stock-based compensation expense  $1,605   $469 

The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands):

 

   Fiscal Year Ended 
   December 28,   December 29, 
   2025   2024 
Cost of revenues  $3,003   $157 
Sales and marketing   2,618    598 
General and administrative   4,867    2,312 
Total stock-based compensation expense  $10,488   $3,067 
Schedule of Fair Value of Stock-Based Compensation  

The following assumptions were used to calculate the fair value of stock-based compensation for the options granted in the fiscal year ended December 29, 2024:

 

Expected term (in years)   5.00 – 6.32 
Expected volatility   58.45% – 62.39 %
Risk-free interest rate   3.81% – 4.71%
Expected dividends   0.0%